This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (403)

Published on in Vol 9, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21430, first published .
Point-of-Care Approaches for Meningitis Diagnosis in a Low-Resource Setting (Southwestern Uganda): Observational Cohort Study Protocol of the “PI-POC” Trial

Point-of-Care Approaches for Meningitis Diagnosis in a Low-Resource Setting (Southwestern Uganda): Observational Cohort Study Protocol of the “PI-POC” Trial

Point-of-Care Approaches for Meningitis Diagnosis in a Low-Resource Setting (Southwestern Uganda): Observational Cohort Study Protocol of the “PI-POC” Trial

Authors of this article:

Giulia Gaudenzi 1, 2 Author Orcid Image ;   Elias Kumbakumba 3 Author Orcid Image ;   Reza Rasti 1 Author Orcid Image ;   Deborah Nanjebe 4 Author Orcid Image ;   Pedro Réu 5 Author Orcid Image ;   Dan Nyehangane 4 Author Orcid Image ;   Andreas Mårtensson 6 Author Orcid Image ;   Milly Nassejje 3 Author Orcid Image ;   Jens Karlsson 7 Author Orcid Image ;   John Mzee 3, 8 Author Orcid Image ;   Peter Nilsson 5 Author Orcid Image ;   Stephen Businge 3, 8 Author Orcid Image ;   Edmund Loh 7, 9 Author Orcid Image ;   Yap Boum II 3, 4 Author Orcid Image ;   Helene Andersson-Svahn 2 Author Orcid Image ;   Jesper Gantelius 2 Author Orcid Image ;   Juliet Mwanga-Amumpaire 3, 4 Author Orcid Image ;   Tobias Alfvén 1 Author Orcid Image
Article Authors Cited by Tweetations (9) Metrics
Giulia Gaudenzi 1, 2*, BSc, MSc, PhD;  Elias Kumbakumba 3*, MD;  Reza Rasti 1*, MD;  Deborah Nanjebe 4, MSc;  Pedro Réu 5, PhD;  Dan Nyehangane 4, MSc;  Andreas Mårtensson 6, MD, PhD;  Milly Nassejje 3, MD;  Jens Karlsson 7, MSc;  John Mzee 3, 8, MD;  Peter Nilsson 5, PhD;  Stephen Businge 3, 8, MD;  Edmund Loh 7, 9, BSc, MSc, PhD;  Yap Boum II 3, 4, PhD;  Helene Andersson-Svahn 2, PhD;  Jesper Gantelius 2, PhD, MD;  Juliet Mwanga-Amumpaire 3, 4, MD;  Tobias Alfvén 1, BSc, MD, PhD

1 Department of Global Public Health, Karolinska Institutet , Stockholm , SE

2 Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm , SE

3 Department of Paediatrics and Child Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara , UG

4 MSF Epicentre Mbarara Research Centre , Mbarara , UG

5 Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm , SE

6 Department of Women's and Children's Health, International Maternal and Child Health, Uppsala University , Uppsala , SE

7 Department of Microbiology, Tumor, and Cell Biology, BioClinicum, Karolinska University Hospital, Stockholm , SE

8 Holy Innocents Children’s Hospital , Mbarara , UG

9 SCELSE, Nanyang Technological University , Singapore , SG

*these authors contributed equally

Corresponding Author:

  • Giulia Gaudenzi, BSc, MSc, PhD
  • Department of Global Public Health
  • Karolinska Institutet
  • Tomtebodavägen 18 A
  • Stockholm
  • SE
  • Phone: 46 763446161
  • Email: giulia.gaudenzi@ki.se